Type 2 Diabetes

>

Latest News

Endocrinology Month in Review: May 2023
Endocrinology Month in Review: May 2023

June 1st 2023

Each month, our editorial staff compiles a recap of the top news in endocrinology from the past month. Our May 2023 month in review features new FDA approvals, important phase 2 data, and in-depth clinician perspective.

One-Third of US Adults with Type 2 Diabetes Show Evidence of Subclinical CVD
One-Third of US Adults with Type 2 Diabetes Show Evidence of Subclinical CVD

May 31st 2023

Deepak Bhatt, MD, MPH | Credit: Mount Sinai Heart
Exploring the Impact of the Sotagliflozin Approval, with Deepak Bhatt, MD, MPH

May 27th 2023

US Food and Drug Adminstration logo in black over a white background | Credit: Food and Drug Administration
FDA Approves Sotagliflozin for Treatment of Heart Failure

May 26th 2023

Elizabeth Selvin, PhD, MPH | Credit: Johns Hopkins Medicine
Earlier Age at Diabetes Onset Confers Greater Risk of Dementia Later in Life

May 25th 2023

Video Series
Video Interviews
Podcasts
Thumbnailor Diabetes Dialogue podcast featuring the podcast logo and headshots of Diana. Isaacs, PharmD, and Natalie Bellini, DNP
Thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of Diana Isaacs, PharmD, and Natalie Bellini, DNP
Logo for Diabetes Dialogue podcast
Thumbnail featuring podcast hosts and logo for Diabetes Dialogue
Diabetes Dialogue thumbnail
Diabetes Dialogue Square Thumbnail
Stuart Weinzimer, MD (Courtesy: Yale Medicine)
Grazia Aleppo, MD
Joanne Rinker, MS, RDN (Courtesy: Twitter)

More News

© 2023 MJH Life Sciences

All rights reserved.